"New Ideas for New Drugs"

var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); ion" CONTENT="Some of the people who have worked most closely with the drug approval system are joining the cAUse of reforming it, says the Wall Street Journal, which notes it has called for reform for some three years. On Jan. 4, the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS, a "> "New Ideas for New Drugs" < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

"New Ideas for New Drugs"

Wall Street Journal (12/28/88), P. A6

Abstract: Some of the people who have worked most closely with the drug approval system are joining the cAUse of reforming it, says the Wall Street Journal, which notes it has called for reform for some three years. On Jan. 4, the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS, a George Bush creation, will hold its first meeting. Nobel Prize winner Gertrude Elion, who will serve on the commission with fellow Nobel winner George Hitchings, says AIDS "may be the first break in the armor of federal regulations, and I believe it could lead to quicker release for drugs against cancer." The defenders of the status quo should explain to AIDS and other patients why they should risk participating in studies in which they may only get a placebo. A cornerstone of new FDA policy may be risk vs. benefit, a concept understood by anyone in pain or whose life is in danger. The Journal says the scientists and regulators in the U.S. research establishment are rediscovering that their primary task is to serve the sick.
881228
AD880425

Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

< type="text/java "> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < type="text/java " src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .